We are live on ! Find out more
DARE icon

Dare Bioscience

14 hedge funds and large institutions have $726K invested in Dare Bioscience in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

15% more capital inflows, than outflows

Capital inflows: $172K | Capital outflows: $150K

0% more funds holding

Funds holding: 14 → 14 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

1.79% less ownership

Funds ownership: 6.91% → 5.12% (-1.8%)

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DARE Hedge Fund Activity: Q2 2019 in Review

14 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2019, worth a combined $726K — down 34% from $1.1M a quarter earlier.

Fund positioning in DARE was balanced in Q2 2019: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $40.7K. The largest seller was Jane Street, exiting entirely with an estimated $65K sold.

  • 14 institutional investors held Dare Bioscience (DARE) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $726K of Dare Bioscience stock for Q2 2019, down 34% quarter-over-quarter.
  • 4 funds opened new Dare Bioscience positions in Q2 2019 and 4 closed out, a net change of 0 holders.
  • The largest Dare Bioscience buyer in Q2 2019 was Renaissance Technologies, an estimated $40.7K added.
  • The largest Dare Bioscience seller in Q2 2019 was Jane Street, an estimated $65K sold.

Based on aggregated 13F filings for Q2 2019.